《沪深股市》上证全日跑输大市 创板高收升3.9% 银行、保险股走弱
内地昨日(17日)新增本土病例继续超过过百宗。人民银行公开市场今日进行2,800亿元人民币(下同)7天期逆回购操作,中标利率持平於2.2%。1月贷款市场报价利率(LPR)维持不变。人民币兑美元中间价上调,上证深成开市个别发展後表现向好,深成、创板大幅反弹,创板高收升近4%。上证午後追上近高收市。
上证高见3,589,全日升16点或0.5%,收报3,583点;深成升219点或1.5%,收报15,223点;沪深300指点升38点或0.7%,收报5,476点。创业板指数升120点或3.9%,以全日高位收报3,204点,成交1,950亿元。沪深两市成交分别为3,971亿元及5,185亿元。
中资金融、保险股走弱,限制大市升幅,工行(601398.SH)、建行(601939.SH)跌1%及2.5%。国寿(601628.SH)、太保(601601.SH)、新华保险(601336.SH)跌2.3%-5.7%。
高铁股上扬,晋西车轴(600495.SH)涨停。太原重工(600169.SH)、中国中车(601766.SH)分别扬6.6%及1.3%。钢铁股上升,永兴材料(002756.SZ)涨停。宝钢股份(600019.SH)、方大特钢(600507.SH)分别扬9.8%及6.1%。
新能源汽车股造好,北汽蓝谷(600733.SH)、苏奥传感(300507.SZ)涨停。江铃汽车(000550.SZ)、小康股份(601127.SH)、江淮汽车(600418.SH)升2%-5.4%。
部份风力发电股上扬,金风科技(002202.SZ)、日月股份(603218.SH)分别升5.2%及7.4%。
医药股走强,泰格医药(300347.SZ)、药明康德(603259.SH)、康龙化成(300759.SZ)涨7.5%-12.2%。昭衍新药(603127.SH)涨停。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.